540204 EIKO

Eiko Lifesciences Share Price

 

 

Start SIP in EIKO

Start SIP

Performance

  • Low
  • ₹50
  • High
  • ₹52
  • 52 Week Low
  • ₹42
  • 52 Week High
  • ₹66
  • Open Price₹52
  • Previous Close₹51
  • Volume4,764
  • 50 DMA₹52.89
  • 100 DMA₹53.03
  • 200 DMA₹53.56

Investment Returns

  • Over 1 Month -3.91%
  • Over 3 Month -1.73%
  • Over 6 Month -9.96%
  • Over 1 Year -7.33%

Smart Investing Starts Here Start SIP with Eiko Lifesciences for Steady Growth!

Invest Now

Eiko Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 20.4
  • PEG Ratio
  • -
  • Market Cap Cr
  • 70
  • P/B Ratio
  • 1.2
  • Average True Range
  • 2.25
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.14
  • RSI
  • 40.21
  • MFI
  • 38.96

Eiko Lifesciences Financials

Eiko Lifesciences Technicals

EMA & SMA

Current Price
₹51.10
+ 0.01 (0.02%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹52.80
  • 50 Day
  • ₹52.89
  • 100 Day
  • ₹53.03
  • 200 Day
  • ₹53.56

Resistance and Support

50.73 Pivot Speed
  • R3 52.60
  • R2 52.06
  • R1 51.27
  • S1 49.94
  • S2 49.40
  • S3 48.61

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Eiko Lifesciences has an operating revenue of Rs. 41.14 Cr. on a trailing 12-month basis. An annual revenue growth of 19% is outstanding, Pre-tax margin of 8% is okay, ROE of 3% is fair but needs improvement. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 58 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 117 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Eiko Lifesciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-12-11 Others Inter alia, To consider the proposal for raising of funds by way of issue of one or more of instruments comprising of Equity Shares, Convertible Securities through Private Placement/Preferential Issue 1) Matter relating to payment of First and final call money on 55,44,178 partly paid-up equity shares of face value of Re. 10/- each which were issued and allotted on August 02, 2023.
2025-10-31 Quarterly Results
2025-07-29 Quarterly Results
2025-05-14 Audited Results
2025-02-12 Quarterly Results

Eiko Lifesciences F&O

Eiko Lifesciences Shareholding Pattern

37.17%
43.36%
19.47%

Eiko Lifesciences FAQs

Eiko Lifesciences share price is ₹51 As on 12 January, 2026 | 01:41

The Market Cap of Eiko Lifesciences is ₹70.1 Cr As on 12 January, 2026 | 01:41

The P/E ratio of Eiko Lifesciences is 20.4 As on 12 January, 2026 | 01:41

The PB ratio of Eiko Lifesciences is 1.2 As on 12 January, 2026 | 01:41

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23